继信瑞诺、亘喜、普方、普米斯、葆元相继被国外药企纳入麾下后,国内巨头也开始出手并购了。来源:Insight 数据库整理7 月 15 日晚间,中国生物制药宣布以 9.5 亿美元的价格,收购礼新医药 95.05% 股权。加上之前获得的 4.91% 股权,交易完成后,礼新医药将成为中国生物制药的全资子公司。此消息一出,业内不少人直呼赚麻了。我们一起来看一下这个交易背后的细节。先说说财务条款,礼新账上其实...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.